NordicCan A/S: Financial statements 2021
CVR: 37633925
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
NordicCan A/S (CVR 37633925) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -4,058,000 compared with DKK -1,987,000 the year before. Equity in the 2021 report amounted to DKK 5,767,000. The solvency ratio was 29.6%.
- Profit/Loss
- DKK -4,058,000
- Equity
- DKK 5,767,000
- Total Assets
- DKK 19,516,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -4.1M | 5.8M | - |
| 2020 | - | 0 | -2M | -175K | - |
| 2019 | - | 84K | -52K | 1.8M | - |
| 2018 | - | -8.3M | -7.7M | 1.9M | 2 |
| 2017 | - | -6K | -7K | 481K | - |
Official annual report
Find more companies like NordicCan A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of September 15, 2021, Lene Lind has joined the board of directors of NordicCan A/S.
As of September 15, 2021, Christopher Beck Lambert has left the board of directors of NordicCan A/S.
NordicCan A/S has published its annual report for 2020. Gross profit came to DKK 0, and the net result was DKK -1,987,000.
About NordicCan A/S
NordicCan A/S was a Danish company of the type Aktieselskab based in Vejle, founded in 2016. The company has been dissolved on 24 March 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MedCan Pharma A/S. The company has 22 employees (2018). In 2021, the company reported a net result of DKK -4,058,000 compared with DKK -1,987,000 the year before. Equity in the 2021 report amounted to DKK 5,767,000.